Financial Assistance for Lymphoma Treatment

Need help with co-pays, deductibles or other expenses? Below you will find organizations that provide co-pay relief, prescription assistance and other types of financial assistance

National Organization for Rare Disorders (NORD)
1-800-999-6673 (voicemail only)
1-203-744-0100
www.rarediseases.org

Assists uninsured or under-insured individuals in securing life-saving or life-sustaining medications including Trisenox, Theracys, and Matulane. Offers co-payment assistance for:

• Advanced Renal Cell Carcinoma
• Hepatocellular Carcinoma
• Hodgkin’s Lymphoma

Patient Access Network Foundation
1-866-316-7263
www.patientaccessnetwork.org

Assists patients who cannot access the treatments they need due to out-of-pocket health care costs including deductibles, co-payments, and co-insurance. Offers assistance for the following specific conditions, among others:

• Cutaneous T-Cell Lymphoma
• Anemia (Covers all patient groups including those with Chemo Induced)
• Non-Hodgkin’s Lymphoma

Leukemia & Lymphoma Society
1-800- 955-4572
www.LLS.org

Leukemia, Lymphoma, Hodgkin’s diseases and Myeloma Grants up to $500 a year for some uncovered expenses including prescriptions, certain medical tests and transportation costs.

Lymphoma Research Foundation
1-800-500-9976
www.lymphoma.org

Lymphomas Grants up to $250 for expenses that include: travel and transportation, temporary lodging, childcare and homecare, cosmetic devices such as wigs and hats, medical devices and hygiene products.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap